Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Japanese Gynecologic Oncology Group

ClinicalTrials.gov Identifier:

NCT00226915

First received: September 23, 2005

Last updated: April 2, 2012

Last verified: April 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2012
Estimated Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)

No publications provided by Japanese Gynecologic Oncology Group

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Katsumata N, Yasuda M, Takahashi F, Isonishi S, Jobo T, Aoki D, Tsuda H, Sugiyama T, Kodama S, Kimura E, Ochiai K, Noda K; Japanese Gynecologic Oncology Group. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial. Lancet. 2009 Oct 17;374(9698):1331-8. Epub 2009 Sep 18.

To Top